Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Mayo Clinic
Mayo Clinic
Washington University School of Medicine
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
Institut Paoli-Calmettes
M.D. Anderson Cancer Center